DCM
DGX icon

Delpha Capital Management’s Quest Diagnostics DGX Stock Holding History

Delpha Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-616
Closed -$61K – 407
2017
Q4 		$61K Buy
+616
New +$58.4K 0.07% 237

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Delpha Capital Management's DGX Position: Q1 2018 in Review

Delpha Capital Management sold out of Quest Diagnostics (DGX) in Q1 2018, closing a stake of 616 shares — an estimated $61K sold.

Delpha Capital Management first reported a position in DGX in Q4 2017 and held it in 1 quarter. The position peaked at $61K in Q4 2017. 653 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

  • Delpha Capital Management reported no remaining Quest Diagnostics position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 616 Quest Diagnostics shares in Q1 2018, an estimated $61K.
  • Delpha Capital Management first reported a position in Quest Diagnostics in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Quest Diagnostics position peaked at $61K in Q4 2017.
  • 653 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.